| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.38B | 91.70B | 88.72B | 82.36B | 75.65B | 68.50B |
| Gross Profit | 19.83B | 20.54B | 18.02B | 14.63B | 15.80B | 15.86B |
| EBITDA | 6.36B | 7.25B | 5.65B | 2.88B | 4.41B | 4.93B |
| Net Income | 2.84B | 3.50B | 2.73B | 485.00M | 1.21B | 1.46B |
Balance Sheet | ||||||
| Total Assets | 63.08B | 64.08B | 67.37B | 63.01B | 61.76B | 62.32B |
| Cash, Cash Equivalents and Short-Term Investments | 14.69B | 15.73B | 15.73B | 12.29B | 12.44B | 12.38B |
| Total Debt | 3.69B | 5.51B | 6.45B | 5.50B | 10.47B | 13.12B |
| Total Liabilities | 23.00B | 24.11B | 28.39B | 26.21B | 25.22B | 26.74B |
| Stockholders Equity | 40.08B | 39.96B | 38.98B | 36.79B | 36.54B | 35.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.07B | 5.68B | 2.94B | 3.53B | 4.55B |
| Operating Cash Flow | 0.00 | 4.59B | 5.96B | 3.53B | 3.76B | 5.20B |
| Investing Cash Flow | 0.00 | -1.06B | -239.00M | -856.00M | -419.00M | -588.00M |
| Financing Cash Flow | 0.00 | -3.53B | -2.28B | -2.82B | -3.28B | -2.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥124.62B | 6.86 | ― | 1.08% | 0.48% | -4.27% | |
72 Outperform | ¥35.97B | 6.02 | ― | 2.23% | -0.25% | -41.09% | |
72 Outperform | ¥1.29T | 18.60 | 11.19% | 1.46% | 2.65% | -5.76% | |
71 Outperform | ¥571.73B | 19.60 | 9.28% | 1.30% | 5.50% | 27.32% | |
69 Neutral | ¥187.97B | 9.91 | 12.56% | 3.44% | 3.80% | 63.03% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥4.36T | 20.92 | 9.46% | 1.32% | 1.99% | -18.79% |